Business Description
TFF Pharmaceuticals Inc
NAICS : 325412
SIC : 2833
ISIN : US87241J2033
Share Class Description:
FRA:0K30: Ordinary SharesDescription
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 47.22 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.5 | |||||
| 3-Year EPS without NRI Growth Rate | 19.1 | |||||
| 3-Year FCF Growth Rate | 25.4 | |||||
| 3-Year Book Growth Rate | -54 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 66.04 | |||||
| 14-Day RSI | 63.72 | |||||
| 6-1 Month Momentum % | 22.9 | |||||
| 12-1 Month Momentum % | -26.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.12 | |||||
| Quick Ratio | 3.12 | |||||
| Cash Ratio | 2.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -38 | |||||
| Shareholder Yield % | 0.83 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -141.69 | |||||
| ROA % | -128.25 | |||||
| ROIC % | -429.21 | |||||
| ROC (Joel Greenblatt) % | -788.27 | |||||
| ROCE % | -145.35 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.76 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | -0.09 | |||||
| EV-to-EBITDA | -0.09 | |||||
| EV-to-Forward-EBITDA | -6.92 | |||||
| EV-to-Forward-Revenue | 9.78 | |||||
| EV-to-FCF | -0.14 | |||||
| Price-to-Net-Current-Asset-Value | 1.41 | |||||
| Price-to-Net-Cash | 2.4 | |||||
| Earnings Yield (Greenblatt) % | -1058.98 | |||||
| FCF Yield % | -218.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TFF Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -11.242 | ||
| Beta | 0.29 | ||
| Volatility % | 48.75 | ||
| 14-Day RSI | 63.72 | ||
| 14-Day ATR (€) | 0.001097 | ||
| 20-Day SMA (€) | 8.91 | ||
| 12-1 Month Momentum % | -26.06 | ||
| 52-Week Range (€) | 0.301 - 17.125 | ||
| Shares Outstanding (Mil) | 2.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TFF Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TFF Pharmaceuticals Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
TFF Pharmaceuticals Inc Frequently Asked Questions
What is TFF Pharmaceuticals Inc(FRA:0K30)'s stock price today?
The current price of FRA:0K30 is €8.91. The 52 week high of FRA:0K30 is €17.13 and 52 week low is €0.30.
When is next earnings date of TFF Pharmaceuticals Inc(FRA:0K30)?
The next earnings date of TFF Pharmaceuticals Inc(FRA:0K30) is 2024-05-10 Est..
Does TFF Pharmaceuticals Inc(FRA:0K30) pay dividends? If so, how much?
TFF Pharmaceuticals Inc(FRA:0K30) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers